Tissue-specific regulation of fat cell lipolysis by NPY in 6-OHDA- treated rats

Peptides

Volumn 18, Issue 6, 1997, Pages 801-808

  Labelle, Martin ^a   Boulanger, Yvan ^a   Fournier, Alain ^a   St Pierre, Serge ^b   Savard, Roland ^b  

^a INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE   (Canada)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Fat cell lipolysis; Neuropeptide Y; Sympathectomy; White adipose tissue

Indexed keywords

NEUROPEPTIDE Y; NEUROPEPTIDE Y [13-36]; NEUROPEPTIDE Y DERIVATIVE; OXIDOPAMINE; PEPTIDE YY;

ADIPOCYTE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL SIZE; CHEMICAL SYMPATHECTOMY; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FOOD INTAKE; LIPOLYSIS; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE SPECIFICITY; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ANIMALS; APPETITE STIMULANTS; BODY WEIGHT; CELL SIZE; EATING; FASTING; FEMALE; LIPOLYSIS; NEUROPEPTIDE Y; OXIDOPAMINE; PEPTIDE FRAGMENTS; PEPTIDE YY; RATS; RATS, WISTAR; RECEPTORS, NEUROPEPTIDE Y; SYMPATHECTOMY, CHEMICAL; SYMPATHOLYTICS;

ANIMALIA;

EID: 0030865080     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00028-4     Document Type: Article

References (37)

1. Adrian T. E., Ferri G.-L., Bacarese-Hamilton A. J., Fuessl H. S., Polak J. M., Bloom S. R. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology. 89:1985;1070-1077.
2. Allen J. M., Raine A. E. G., Ledingham J. C. G., Bloom S. R. Neuropeptide Y: A novel renal peptide with vasoconstrictor and natriuretic activity. Clin. Sci. 68:1985;373-377.
3. Aubert J. F., Waeber B., Rossier B., Geering K., Nussberger J., Brunner H. R. Effects of neuropeptide Y on the blood pressure response to various vasoconstrictor agents. J. Pharmacol. Exp. Ther. 246:1988;1088-1092.
4. Bard J. A., Walker M. W., Branchek T. A., Weinshank R. L. Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y and peptide YY. J. Biol. Chem. 270:1995;26762-26765.
5. Berlan M., Lafontan M. Evidence that epinephrine acts preferentially as an antilipolytic agent in abdominal human subcutaneous fat cells: Assessment by analysis of beta and alpha2-adrenoreceptor properties. Eur. J. Clin. Invest. 15:1985;341-348.
6. Cannon B., Nedergaard J., Lundberg J. M., Hökfelt T., Terenius L., Goldstein M. Neuropeptide tyrosine (NPY) is co-stored with noradrenaline in vascular but not in parenchymal sympathetic nerves of brown adipose tissue. Exp. Cell Res. 164:1986;546-550.
7. Castan I., Valet P., Lafontan M. Le récepteur du PYY: Un élément important du système antilipolytique de l'adipocyte. Med. Sci. 10:1994;196-201.
8. 2 -adrenergic system. Am. J. Physiol. 265:1993;E74-E80.
9. 1 in mammal adipocytes. Am. J. Physiol. 266:1994;R1141-R1147.
10. Castan I., Valet P., Voisin T., Quideau N., Laburthe M., Lafontan M. Identification and functional studies of a specific peptide YY-preferring receptor in dog adipocytes. Endocrinology. 131:1992;1970-1976.
11. Chaudhry A., MacKenzie R. G., Georgic L. M., Granneman J. G. Differential interaction of beta 1- and beta 3-adrenergic receptors with Gi in rat adipocytes. Cell Signal. 6:1994;457-465.
12. Clark J. T., Kalra P. S., Crowley W. R., Kalra S. P. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology. 115:1984;427-429.
13. Cousin B., Casteilla L., Lafontan M., Ambid L., Langin D., Berthault M.-F., Pénicaud L. Local sympathetic denervation of white adipose tissue in rats induces preadipocyte proliferation without noticeable changes in metabolism. Endocrinology. 133:1993;2255-2262.
14. Fournier A., Gagnon D., Quirion R., Cadieux A., Dumont Y., Pheng L.-H., St.-Pierre S. Conformational and biological studies of neuropeptide Y analogs containing structural alterations. Mol. Pharmacol. 45:1994;93-101.
15. Gerald C., Walker M. W., Criscione L., Gustafson E. L., Batzl-Hartmann C., Smith K. E., Vaysse P., Durkin M. M., Laz T. M., Linemeyer D. L., Schaffhauser A. O., Whitebread S., Hofbauer K. G., Taber R. I., Branchek T. A., Weinshank R. L. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature. 382:1996;168-171.
16. Girouard H., Pirouzi P., Robidoux J., Lafond J., Savard R. L'effet des prostaglandines de type E2 et I2 sur la stimulation de la lipolyse adipocytaire par le 17- β -estradiol. Med. Sci. Suppl. 1:1994;36.
17. Guy J., Li S., Pelletier G. Studies of the physiological role and mechanism of action of neuropeptide Y in the regulation of luteinizing hormone secretion in the rat. Regul. Pept. 23:1988;209-216.
18. Hackenthal E., Aktories K., Jakobs K. H., Lang R. E. Neuropeptide Y inhibits renin release by a pertussis toxin-sensitive mechanism. Am. J. Physiol. 252:1987;F543-F550.
19. Kather H. Beta-adrenergic stimulation of adenine nucleotide metabolism and purine release in human adipocytes. J. Clin. Invest. 85:1990;106-114.
20. Kather H., Schroder F., Simon B. Microdetermination of glycerol using bacterial NADH-linked luciferase. Clin. Chim. Acta. 120:1982;295-300.
21. Lundberg J. M., Tatemoto K. Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to α -adrenoreceptor blockage. Acta Physiol. Scand. 116:1982;393-402.
22. Negishi M., Sugimoto Y., Ichikawa A. Molecular mechanisms of diverse actions of prostanoid receptors. Biochim. Biophys. Acta. 1259:1995;109-120.
23. Pfister A., Waeber B., Nussberger J., Brunner H. R. Neuropeptide Y normalizes renin secretion in adrenalectomized rat without changing blood pressure. Life Sci. 39:1986;2161-2167.
24. Robidoux J., Pirouzi P., Lafond J., Savard R. Site-specific effects of sympathectomy on the adrenergic control of lipolysis in hamster fat cells. Can. J. Physiol. Pharmacol. 73:1995;450-458.
25. Rodbell M. Metabolism of isolated fat cells. Effects of hormones on glucose metabolism and lipolysis. J. Biol. Chem. 239:1964;375-380.
26. Savard R., Greenwood M. R. C. Site specificity of fat cell lipolysis during pregnancy in two strains of rats. Can. J. Physiol. Pharmacol. 71:1993;234-240.
27. Stanley B. G., Kyrkouli S. E., Lampert S., Leibowitz S. F. Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity. Peptides. 7:1986;1189-1192.
28. Suzuki T., Nakaya M., Itoh Z., Tatemoto K., Mutt V. Inhibition of interdigestive contractile activity in the stomach by peptide YY in Heidenhain pouch dogs. Gastroenterology. 85:1983;114-121.
29. Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y - A novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 296:1982;659-660.
30. Toth P. T., Bindokas V. P., Bleakman D., Colmers W. F., Miller R. J. Mechanism of presynaptic inhibition by neuropeptide Y at sympathetic nerve terminals. Nature. 364:1993;635-638.
31. Valet P., Berlan M., Beauville M., Crampes F., Montastruc J. L., Lafontan M. Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein. J. Clin. Invest. 85:1990;291-295.
32. Waeber B., Evequoz D., Aubert J. F., Flückiger J. P., Juillerat L., Nussberger J., Brunner H. R. Prevention of renal hypertension in the rat by neuropeptide Y. J. Hypertension. 8:1990;21-25.
33. Wahlestedt C., Regunathan S., Reis D. J. Identification of cultured cells selectively expressing Y1-, Y2-, or Y3-type receptors for neuropeptide Y/peptide YY. Life Sci. 50:1991;7-12.
34. Wahlestedt C., Yanaihara N., Håkanson R. Evidence for different pre- and post-junctional receptors for neuropeptide Y. Regul. Pept. 13:1986;307-318.
35. Weinberg D. H., Sirinathsinghji D. J. S., Tan C. P., Shialo L.-L., Morin N., Rigby M. R., Heavens R. H., Rapoport D. R., Bayne M. L., Cascieri M. A., Strader C. D., Linemeyer D. L., MacNeil D. J. Cloning and expression of a novel neuropeptide Y receptor. J. Biol. Chem. 271:1996;16435-16438.
36. Weinkove C. Measurement of catecholamines and their metabolites in urine. Assoc. Clin. Pathol. Broadsheet. 127:1991;1-7.
37. Yamada S., Yamamura H. I., Roeske W. R. Effects of chemical sympathectomy with 6-hydroxydopamine on α - and β -adrenoreceptors and muscarinic cholinoceptors in rat kidney. Eur. J. Pharmacol. 121:1986;345-353.